← Company directoryNASDAQ · SEC EDGAR
Integra LifeSciences Holdings Corporation
IARTA primary-source company identity page built for fast discovery, filing verification and consistent financial research.
SHARE PRICE · INDICATIVE——
A recent price could not be verified. Check the exchange before trading.
ANALYSIS ROUTE
Four checks before any decision
Business model
Understand how the company earns and where demand originates.
Revenue and margin
Compare equivalent periods; separate growth from profitability.
Debt and cash flow
Test balance-sheet resilience and cash conversion.
Valuation and risk
Use sector peers, scenarios and explicit risk limits.
Company calendar
Integra LifeSciences Q3 2026 results
Integra LifeSciences will release third-quarter 2026 financial results before the U.S. market opens on October 21. The company did not announce an exact publication minute; demand and profitability in neurosurgery and tissue-reconstruction products will be in focus.
Integra LifeSciences ↗Integra LifeSciences Q3 2026 earnings call
Integra LifeSciences management will discuss third-quarter results at 8:30 AM Eastern on October 21, equivalent to 15:30 in Istanbul.
Integra LifeSciences ↗More NASDAQ records
Alphabetically adjacent directory records for faster navigation; this is not a peer or valuation classification.
IACOWIdea Acquisition Corp. - WarrantsNASDAQ · SEC→IACQIrenic Acquisition Corp. - Class A Ordinary SharesNASDAQ · SEC→IACQUIrenic Acquisition Corp. - UnitNASDAQ · SEC→IACQWIrenic Acquisition Corp. - WarrantsNASDAQ · SEC→IBACIB Acquisition Corp.NASDAQ · SEC→IBACRIB Acquisition Corp. - RightNASDAQ · SEC→IBCPIndependent Bank CorporationNASDAQ · SEC→IBEXIBEX Limited - Common ShareNASDAQ · SEC→
DATA STATUS
Open official filings ↗Checking SEC financial statements
A dash means standardized data is unavailable. Always check the filing period, currency and accounting scope.